AGI-5198,突变体异柠檬酸脱氢酶1(mIDH1)的有效抑制剂

AGI-5198 (订货以英文为准)

编号:A126546
CAS号:1355326-35-0
分子式:C27H31FN4O2
分子量:462.56
货号 品牌 包装 目录价 您的价格 库存 数量 购买
A126546-100mg 阿拉丁 100mg ¥871.90
A126546-25mg 阿拉丁 25mg ¥378.90
A126546-5mg 阿拉丁 5mg ¥165.90
产品名称 AGI-5198
中文名称 AGI-5198,突变体异柠檬酸脱氢酶1(mIDH1)的有效抑制剂
CAS号 1355326-35-0
分子式(M.F.) C27H31FN4O2
分子量(M.W.) 462.56
储存条件 -20°C储存
溶解性DMSO 24 mg/mL Water <1 mg/mL Ethanol 14 mg/mL
存贮条件储存温度-20°C
应用AGI-5198(IDH C35)是剂量依赖的R132H-IDH1抑制剂
产品介绍AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM.
备注AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM.
生化机理Description:IC50 Value: N/AAGI-5198, a novel R132H-IDH1 inhibitor, identified through a high-throughput screen blocked, in a dose-dependent manner, the ability of the mutant enzyme (mIDH1) to produce R-2-hydroxyglutarate (R-2HG). The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metabolism of cancer cells for cancer therapy. Isocitrate dehydrogenase 1 (IDH1) is one potential drug target, which is mutated in multiple human cancers [1].in vitro: N/Ain vivo: N/AClinical trial: N/A
别名;IDH-C35;AGI5198;AGI 5198;IDH C35;N-Cycohexyl-2-(N-(3-fluorophenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamido)-2-(o-tolyl)acetamide; N-[2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-1H-imidazole-1-acetamide
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:86-57-7
¥ 588.00 N814508-100g
CAS号:1314-56-3
¥ 59.90 P116348-100g
¥ 1460.00 LR-HP9015B-1台
CAS号:25322-68-3
¥ 158.00 013685317-25g
CAS号:110-63-4
¥ 62.00 01007907-500mL
¥ 240.00 GBW(E)130035-35g
¥ 1780.00 3123000284-1把
CAS号:78-67-1
¥ 160.00 016546525-25g
CAS号:25322-68-3
¥ 178.00 60304ES76-500g